ASX-listed MGC Pharmaceuticals announced today that is has been awarded a contract to build a medical cannabis production facility in Malta, with a $5 million capital raising set to help fund the project.

ASX-listed MGC Pharmaceuticals announced today that is has been awarded a contract to build a medical cannabis production facility in Malta, with a $5 million capital raising set to help fund the project.